Premier Biomedical Inc (BIEI) |
|
|
|
Premier Biomedical Inc Growth Comparisons
Select each growth Category to receive further Information
Select the Comparisons :
|
|
Select the Ratio:
|
|
BIEI's Growth Comparisons in IV. Quarter 2019
Premier Biomedical Inc reported top-line of $ 0 millions in the forth quarter 2019, compare to $ 0 millions in the same quarter a year ago. Revenues in the Biotechnology & Pharmaceuticals industry grew by 8.35%, while the top-line in the Healthcare sector increased by 3.53%, and overall market improved by 1.72% from the forth quarter 2018. Top-line fell by -62.31% from the third quarter results. Comparing the annual growth, sales of % on average in last five years, to the S & P 500's, including only Businesses with the forth quarter 2019 financial results, average yearly sales growth is 10.53%. Premier Biomedical Inc grew less than the market.
Growth Rates of BIEI's Income in the forth quarter 2019
BIEI's EPS Growth Rates
Premier Biomedical Inc reported bottom-line of $ 0.00 in the forth quarter, compare to $ -0.17 in the same quarter a year ago. Biotechnology & Pharmaceuticals industry grew by 8.35%, while Healthcare sector increased by 3588.76%, and overall market declined by -5.61%. Bottom-line fell by -62.31% from the third quarter results. Comparing the annual growth, income per share of % on average in last five years, to the S & P 500's, including only Businesses with the forth quarter 2019 earnings, average yearly income per share growth is 11.58%. Premier Biomedical Inc grew less than the market.
BIEI Cash Flow Growth Rates
|